Penile Neoplasms
Information
- Disease name
- Penile Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01728233 | Completed | Phase 2 | Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis | June 15, 2013 | September 21, 2018 |
| NCT03012581 | Completed | Phase 2 | Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types | June 16, 2017 | November 11, 2023 |
| NCT03774901 | Recruiting | Phase 2 | Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma | March 12, 2019 | September 22, 2024 |
| NCT05578820 | Recruiting | Phase 1 | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid | January 1, 2022 | December 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010412